Ascendia

With more insoluble chemical entities emerging from the drug discovery pipeline comes the challenge of finding the appropriate technology for improving solubility and bioavailability. Ascendia’s enabling platform technologies can help overcome these challenges by designing better and smarter formulations for oral and parenteral drug molecules across all modalities. Ascendia’s expertise and cGMP capabilities in manufacturing of innovative and complex generics can help expedite the development process of oral and injectable drugs, and reduce time and cost.

https://www.pharmtech.com/pt/nanotechnologies

How to tackle poorly soluble molecules across all modalities

What to know about polymeric nanoparticles (PNPs) and lipid nanoparticles (LNPs)

cGMP manufacturing and capabilities of PNPs/LNPs

Formulation scientists working with poorly soluble small and large molecules

Managers, vice presidents and chief scientific officers working with challenging molecules

Students and professors interested in innovative approaches for improving the solubility and bioavailability of molecules


Sr. Director Scientific Affairs and Technical Marketing
Ascendia Pharma

 joins Ascendia Pharmaceuticals Inc. as senior director of scientific affairs and technical marketing after having worked in the pharma and biotech industry for nearly 30 years. His areas of expertise include lipid chemistry; liposomes; surfactant-based drug delivery systems; SEDDS/SMEDDS; amorphous solid dispersions; oral, parenteral, topical and transdermal drug delivery; and immediate and controlled release formulations. He received his PhD in Organic Chemistry from the City University of New York and received postdoctoral training in Physical Biochemistry of lipids at the University of Minnesota and Cornell University.

Dr Ali has published over 60 articles in scientific journals and is an inventor/coinventor of several US and European patents. He is the recipient of IPEC’s Henk de Jong Industrial Research Award. He has served as the USP council of experts for the General Chapters-Physical Analysis (2010-2020), and continues to serve as USP council of experts for the Excipient Test Methods committee (2020-2025). He is co-chair of the AAPS Lipid Focus Group.


Webcasts

Webinar Date/Time: Thu, Nov 2, 2023 2:00 PM EDT

Frontiers in Nanotechnologies for Delivery of Small Molecules and Biologics

Learn about the challenges with poorly soluble drugs, the sterile and non-sterile capabilities for injectable and oral formulations, and more!

https://www.pharmtech.com/pt_w/nanoparticle-platform

Enabling technologies to overcome the solubility and bioavailability challenges for oral and parenteral formulations

Sterile and non-sterile capabilities for injectable and oral formulations

Formulators working in early phase pre-formulation/formulation and manufacturing of innovative molecules

Industry leaders (CSO, VP, R&D, Managers) with interest in lipid nanoparticles and drug delivery of biologics and large molecules

Students and faculty from universities working in the lipid nanoparticles and drug delivery


Sr. Director Scientific Affairs & Technical Marketing
Ascendia Pharmaceuticals


 has over 29 years in the pharmaceutical industry. He has expertise in lipids and liposomes drug delivery, and drug discovery and formulations development. Dr. Ali received his PhD in Chemistry from the City University of New York and postdoc training at the University of Minnesota and Cornell University. He has published over 50 articles in scientific journals and inventor/co-inventor of 14 US patents. He is a member of AAPS and ACS. He has served as a member of the editorial advisory board on many leading industry publications and journals, and has had the opportunities to serve as a USP panel of expert in General Chapters- Physical Analysis (1010-2020) and Excipient Test Methods committee (2020-2025). He is the recipient of IPEC Foundation’ 2020 Henk de Jong industrial research award for his contributions to formulations and excipient technologies.



Webinar Date/Time: Tue, Feb 28, 2023 2:00 PM EST

Nanoparticle Platform Technologies for Efficient Oral and Parenteral Drug Delivery

Articles

This white paper from outlines the best steps to establish an efficient drug formulation development process to stay within budget and meet timelines. 